Jun 30, 2020
InMed Announces Completion of Share Consolidation
Jun 24, 2020
InMed Introduces IntegraSyn(TM): An Integrated Cannabinoid Manufacturing System
Jun 19, 2020
InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation
May 27, 2020
InMed Releases CBN Preclinical Results in Glaucoma
May 19, 2020
InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
May 14, 2020
InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
May 12, 2020
InMed Files PCT Patent Application for Neuroprotection in Glaucoma
May 08, 2020
InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
May 07, 2020
InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
May 05, 2020
InMed and Almac Group Developing Improved Cannabinoid Production Methods
Apr 30, 2020
InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
Apr 01, 2020
InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 24, 2020
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
Mar 20, 2020
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Feb 14, 2020
InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
Feb 07, 2020
InMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020
Jan 21, 2020
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
Jan 20, 2020
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
Jan 16, 2020
InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress